Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-2-8
pubmed:databankReference
pubmed:abstractText
Skin-infiltrating lymphocytes expressing type 1 cytokines have been linked to the pathophysiology of psoriasis. We evaluated the safety and efficacy of a human interleukin-12/23 monoclonal antibody in treating psoriasis.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2007 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
8
pubmed:volume
356
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
580-92
pubmed:dateRevised
2008-1-29
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
pubmed:affiliation
University of Utah, Salt Lake City, USA. gerald.krueger@derm.med.utah.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II